Photodiagnosis and Photodynamic Therapy
Volume 5, Issue 1 , Pages 19-28 , March 2008

Bio-nanotechnology and photodynamic therapy—State of the art review

  • R.R. Allison

      Affiliations

    • Brody School of Medicine at ECU, Radiation Oncology, 600 Moye Blvd LJCC172, Greenville, NC 28758, United States
    • ,
  • H.C. Mota

      Affiliations

    • Brody School of Medicine at ECU, Radiation Oncology, 600 Moye Blvd LJCC172, Greenville, NC 28758, United States
    • ,
  • V.S. Bagnato

      Affiliations

    • Instituto de Fisica de São Carlos, Universidade de São Paulo, Av Trabalhadores Sancarlense, 400, São Carlos, SP 13566-590, Brazil
    • ,
  • C.H. Sibata, PhD

      Affiliations

    • Brody School of Medicine at ECU, Radiation Oncology, 600 Moye Blvd LJCC172, Greenville, NC 28758, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 252 744 2900; fax: +1 252 744 2812.

References 

  1. Kasemo B. Biological surface science. Curr Opin Solid State Mater Sci. 1998;3(5):451–459
  2. Narducci D. An introduction to nanotechnologies: what's in it for us?. Vet Res Commun. 2007;31(Suppl. 1):131–137
  3. Rosi NL, Mirkin CA. Nanostructures in biodiagnostics. Chem Rev. 2005;105(4):1547–1562
  4. Stupp SI. Introduction: functional nanostructures. Chem Rev. 2005;105(4):1023–1024
  5. Emerich DF, Thanos CG. The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis. Biomol Eng. 2006;23(4):171–184
  6. Roduner E. Size matters: why nanomaterials are different. Chem Soc Rev. 2006;35(7):583–592
  7. Allison RR, Mota HC, Sibata CH. Clinical PD/PDT in North America: an historical review. Photodiag Photodyna Ther. 2004;1(4):263–277
  8. Dougherty TJ, Gomer CJ, Henderson BW, et al. Photodynamic therapy. J Natl Cancer Inst. 1998;90(12):889–905
  9. Allison RR, Downie GH, Cuenca R, Hu XH, Childs CJH, Sibata CH. Photosensitizers in clinical PDT. Photodiag Photodyna Ther. 2004;1(1):27–42
  10. Pass HI. Photodynamic therapy in oncology: mechanisms and clinical use. J Natl Cancer Inst. 1993;85(6):443–456
  11. Bonnett R, Berenbaum M. Porphyrins as photosensitizers. Ciba Found Symp. 1989;146:40–53discussion 53-9
  12. Konan YN, Gurny R, Allemann E. State of the art in the delivery of photosensitizers for photodynamic therapy. J Photochem Photobiol B. 2002;66(2):89–106
  13. Moser JG. 2nd and 3rd generation photosensitizers. Amsterdam: Harwood Academic Publishers; 1998;
  14. Carruth JA. Clinical applications of photodynamic therapy. Int J Clin Pract. 1998;52(1):39–42
  15. Panjehpour M, Overholt BF, Haydek JM. Light sources and delivery devices for photodynamic therapy in the gastrointestinal tract. Gastrointest Endosc Clin N Am. 2000;10(3):513–532
  16. Mang T. Lasers and light sources for PDT: past, present and future. Photodiagn Photodyn Ther. 2004;1(1):43–48
  17. Chen J, Keltner L, Christophersen J, et al. New technology for deep light distribution in tissue for phototherapy. Cancer J. 2002;8(2):154–163
  18. Scourides PA, Bohmer RM, Kaye AH, Morstyn G. Nature of the tumor-localizing components of hematoporphyrin derivative. Cancer Res. 1987;47(13):3439–3445
  19. Peng Q, Farrants GW, Madslien K, et al. Subcellular localization, redistribution and photobleaching of sulfonated aluminum phthalocyanines in a human melanoma cell line. Int J Cancer. 1991;49(2):290–295
  20. Rosenkranz AA, Jans DA, Sobolev AS. Targeted intracellular delivery of photosensitizers to enhance photodynamic efficiency. Immunol Cell Biol. 2000;78(4):452–464
  21. Sibata CH, Colussi VC, Oleinick NL, Kinsella TJ. Photodynamic therapy in oncology. Expert Opin Pharmacother. 2001;2(6):917–927
  22. Patterson MS, Wilson BC, Graff R. In vivo tests of the concept of photodynamic threshold dose in normal rat liver photosensitized by aluminum chlorosulphonated phthalocyanine. Photochem Photobiol. 1990;51(3):343–349
  23. Wilson BC, Patterson MS, Lilge L. Implicit and explicit dosimetry in photodynamic therapy: a new paradigm. Lasers Med Sci. 1997;12:182–199
  24. Singh S, Nalwa HS. Nanotechnology and health safety—toxicity and risk assessments of nanostructured materials on human health. J Nanosci Nanotechnol. 2007;7(9):3048–3070
  25. Nowack B, Bucheli TD. Occurrence, behavior and effects of nanoparticles in the environment. Environ Pollut. 2007;150(1):5–22
  26. Lam CW, James JT, McCluskey R, Arepalli S, Hunter RL. A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks. Crit Rev Toxicol. 2006;36(3):189–217
  27. Aitken RJ, Chaudhry MQ, Boxall AB, Hull M. Manufacture and use of nanomaterials: current status in the UK and global trends. Occup Med (Lond). 2006;56(5):300–306
  28. Bosi S, Da Ros T, Spalluto G, Prato M. Fullerene derivatives: an attractive tool for biological applications. Eur J Med Chem. 2003;38(11/12):913–923
  29. Zhou Q, Xiao J, Wang W. Using multi-walled carbon nanotubes as solid phase extraction adsorbents to determine dichlorodiphenyltrichloroethane and its metabolites at trace level in water samples by high performance liquid chromatography with UV detection. J Chromatogr A. 2006;1125(2):152–158
  30. Cai Y, Jiang G, Liu J, Zhou Q. Multiwalled carbon nanotubes as a solid-phase extraction adsorbent for the determination of bisphenol A, 4-n-nonylphenol, and 4-tert-octylphenol. Anal Chem. 2003;75(10):2517–2521
  31. Jain KK. Applications of nanobiotechnology in clinical diagnostics. Clin Chem. 2007;53(11):2002–2009
  32. Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006;311(5761):622–627
  33. Lead JR, Wilkinson KJ. Aquatic colloids and nanoparticles: current knowledge and future trends. Environ Chem. 2006;3(3):151–171
  34. Cohen ML. Nanotubes, nanoscience, and nanotechnology. Mater Sci Eng: C. 2001;15(1/2):1–11
  35. Monson E, Brasuel M, Philbert MA, Kopelman R. PEBBLE nanosensors for in vitro bioanalysis. In:  Vo-Dinh T editors. Biomedical Photonics Handbook. Boca Raton, FL: CRC Press; 2003;p. 59–61
  36. Jain KK. Challenges of drug discovery for personalized medicine. Curr Opin Mol Ther. 2006;8(6):487–492
  37. Huang X, Jain PK, El-Sayed IH, El-Sayed MA. Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomed. 2007;2(5):681–693
  38. Bao YP, Wei TF, Lefebvre PA, et al. Detection of protein analytes via nanoparticle-based bio bar code technology. Anal Chem. 2006;78(6):2055–2059
  39. Agrawal A, Tripp RA, Anderson LJ, Nie S. Real-time detection of virus particles and viral protein expression with two-color nanoparticle probes. J Virol. 2005;79(13):8625–8628
  40. Koo YE, Fan W, Hah H, et al. Photonic explorers based on multifunctional nanoplatforms for biosensing and photodynamic therapy. Appl Opt. 2007;46(10):1924–1930
  41. El-Sayed IH, Huang X, El-Sayed MA. Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. Cancer Lett. 2006;239(1):129–135
  42. Richter AM, Yip S, Meadows H, et al. Photosensitizing potencies of the structural analogues of benzoporphyrin derivative in different biological test systems. J Clin Laser Med Surg. 1996;14(5):335–341
  43. Berg K, Moan J, Lysosomes . microtubules as targets for photochemotherapy of cancer. Photochem Photobiol. 1997;65(3):403–409
  44. Roy I, Ohulchanskyy TY, Pudavar HE, et al. Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. J Am Chem Soc. 2003;125(26):7860–7865
  45. Konan YN, Berton M, Gurny R, Allemann E. Enhanced photodynamic activity of meso-tetra(4-hydroxyphenyl)porphyrin by incorporation into sub-200nm nanoparticles. Eur J Pharm Sci. 2003;18(3/4):241–249
  46. Konan YN, Cerny R, Favet J, Berton M, Gurny R, Allemann E. Preparation and characterization of sterile sub-200nm meso-tetra(4-hydroxylphenyl)porphyrin-loaded nanoparticles for photodynamic therapy. Eur J Pharm Biopharm. 2003;55(1):115–124
  47. Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev. 2004;56(11):1649–1659
  48. Kim G, Huang SW, Day KC, et al. Indocyanine-green-embedded PEBBLEs as a contrast agent for photoacoustic imaging. J Biomed Opt. 2007;12(4):044020
  49. Kim S, Ohulchanskyy TY, Pudavar HE, Pandey RK, Prasad PN. Organically modified silica nanoparticles co-encapsulating photosensitizing drug and aggregation-enhanced two-photon absorbing fluorescent dye aggregates for two-photon photodynamic therapy. J Am Chem Soc. 2007;129(9):2669–2675
  50. Bhawalkar JD, Kumar ND, Zhao CF, Prasad PN. Two-photon photodynamic therapy. J Clin Laser Med Surg. 1997;15(5):201–204
  51. Gomes AJ, Lunardi LO, Marchetti JM, Lunardi CN, Tedesco AC. Photobiological and ultrastructural studies of nanoparticles of poly(lactic-co-glycolic acid)-containing bacteriochlorophyll-a as a photosensitizer useful for PDT treatment. Drug Deliv. 2005;12(3):159–164
  52. Reddy GR, Bhojani MS, McConville P, et al. Vascular targeted nanoparticles for imaging and treatment of brain tumors. Clin Cancer Res. 2006;12(22):6677–6686
  53. Gomes AJ, Lunardi CN, Tedesco AC. Characterization of biodegradable poly(d,l-lactide-co-glycolide) nanoparticles loaded with bacteriochlorophyll-a for photodynamic therapy. Photomed Laser Surg. 2007;25(5):428–435
  54. Allemann E, Brasseur N, Benrezzak O, et al. PEG-coated poly(lactic acid) nanoparticles for the delivery of hexadecafluoro zinc phthalocyanine to EMT-6 mouse mammary tumours. J Pharm Pharmacol. 1995;47(5):382–387
  55. Allemann E, Rousseau J, Brasseur N, Kudrevich SV, Lewis K, van Lier JE. Photodynamic therapy of tumours with hexadecafluoro zinc phthalocynine formulated in PEG-coated poly(lactic acid) nanoparticles. Int J Cancer. 1996;66(6):821–824
  56. Ricci-Junior E, Marchetti JM. Zinc(II) phthalocyanine loaded PLGA nanoparticles for photodynamic therapy use. Int J Pharm. 2006;310(1/2):187–195
  57. Pegaz B, Debefve E, Borle F, Ballini JP, van den Bergh H, Kouakou-Konan YN. Encapsulation of porphyrins and chlorins in biodegradable nanoparticles: the effect of dye lipophilicity on the extravasation and the photothrombic activity. A comparative study. J Photochem Photobiol B. 2005;80(1):19–27
  58. Konan YN, Chevallier J, Gurny R, Allemann E. Encapsulation of p-THPP into nanoparticles: cellular uptake, subcellular localization and effect of serum on photodynamic activity. Photochem Photobiol. 2003;77(6):638–644
  59. Pitsillides CM, Joe EK, Wei X, Anderson RR, Lin CP. Selective cell targeting with light-absorbing microparticles and nanoparticles. Biophys J. 2003;84(6):4023–4032
  60. Tang W, Xu H, Kopelman R, Philbert MA. Photodynamic characterization and in vitro application of methylene blue-containing nanoparticle platforms. Photochem Photobiol. 2005;81(2):242–249
  61. Wieder ME, Hone DC, Cook MJ, Handsley MM, Gavrilovic J, Russell DA. Intracellular photodynamic therapy with photosensitizer-nanoparticle conjugates: cancer therapy using a ‘Trojan horse’. Photochem Photobiol Sci. 2006;5(8):727–734
  62. Gu H, Xu K, Yang Z, Chang CK, Xu B. Synthesis and cellular uptake of porphyrin decorated iron oxide nanoparticles-a potential candidate for bimodal anticancer therapy. Chem Commun (Camb). 2005;34:4270–4272
  63. Zheng G, Chen J, Li H, Glickson JD. Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents. Proc Natl Acad Sci USA. 2005;102(49):17757–17762
  64. Xu J, Sun Y, Huang J, et al. Photokilling cancer cells using highly cell-specific antibody-TiO(2) bioconjugates and electroporation. Bioelectrochemistry. 2007;71(2):217–222
  65. Zuluaga MF, Mailhos C, Robinson G, Shima DT, Gurny R, Lange N. Synergies of VEGF inhibition and photodynamic therapy in the treatment of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2007;48(4):1767–1772
  66. Tada DB, Vono LL, Duarte EL, et al. Methylene blue-containing silica-coated magnetic particles: a potential magnetic carrier for photodynamic therapy. Langmuir. 2007;23(15):8194–8199
  67. Cinteza LO, Ohulchanskyy TY, Sahoo Y, Bergey EJ, Pandey RK, Prasad PN. Diacyllipid micelle-based nanocarrier for magnetically guided delivery of drugs in photodynamic therapy. Mol Pharm. 2006;3(4):415–423
  68. Lee C, Hsu C. Nano-structure enhanced organic light emitting diodes made with CdSe(ZnS) quantum dots and a semiconducting polymer. In: 5th IEEE conference on nanotechnology. 2005;
  69. Bagnato VS. In: VS Bagnato, editor. Progress Report of CEPOF. São Carlos: Instituto de Fisica de São Carlos; 2007.
  70. Hayden O, Payne CK. Nanophotonic light sources for fluorescence spectroscopy and cellular imaging. Angew Chem Int Ed Engl. 2005;44(9):1395–1398
  71. Chen W, Zhang J. Using nanoparticles to enable simultaneous radiation and photodynamic therapies for cancer treatment. J Nanosci Nanotechnol. 2006;6(4):1159–1166
  72. Xu S, Shen J, Chen S, Zhang M, Shen T. Active oxygen species (1O2, O2*-) generation in the system of TiO2 colloid sensitized by hypocrellin B. J Photochem Photobiol B. 2002;67(1):64–70
  73. Wang X, Zhang Z, Tang Z, Lin Y. Characterization and properties of a red and orange Y2O2S-based long afterglow phosphor. Mater Chem Phys. 2003;80(1):1–5
  74. Choi JS, Jun YW, Yeon SI, Kim HC, Shin JS, Cheon J. Biocompatible heterostructured nanoparticles for multimodal biological detection. J Am Chem Soc. 2006;128(50):15982–15983
  75. Cao Y, Koo YE, Koo SM, Kopelman R. Ratiometric singlet oxygen nano-optodes and their use for monitoring photodynamic therapy nanoplatforms. Photochem Photobiol. 2005;81(6):1489–1498

PII: S1572-1000(08)00009-4

doi: 10.1016/j.pdpdt.2008.02.001

Photodiagnosis and Photodynamic Therapy
Volume 5, Issue 1 , Pages 19-28 , March 2008

Article Tools